Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.630
-0.020 (-0.75%)
May 26, 2026, 1:26 PM EDT - Market open
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $7 million as of May 26, 2026. Its market cap has increased by 112.00% in one year.
Market Cap
7.00M
Enterprise Value
5.32M
1-Year Change
112.00%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $7.00M, a decrease of -79.66%. That is a compound annual growth rate of -24.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 7.30M | 12.31% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 7.60M |
| Evogene | 7.50M |
| Immuron | 7.45M |
| Acurx Pharmaceuticals | 7.23M |
| Can-Fite BioPharma | 7.16M |
| Addex Therapeutics | 7.00M |
| Xenetic Biosciences | 6.94M |
| Aptorum Group | 6.92M |